Phio Pharmaceuticals Corp. (PHIO)’s Financial Results Comparing With Jaguar Health Inc. (NASDAQ:JAGX)

This is a contrast between Phio Pharmaceuticals Corp. (NASDAQ:PHIO) and Jaguar Health Inc. (NASDAQ:JAGX) based on their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. The two companies are Biotechnology and they also compete with each other.

Valuation and Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Phio Pharmaceuticals Corp. N/A 42.86 7.63M -2.54 0.00
Jaguar Health Inc. 4.36M 1.68 40.69M -5.21 0.00

Table 1 shows top-line revenue, earnings per share (EPS) and valuation of the two companies.


Table 2 shows us the return on equity, return on assets and net margins of both businesses.

Net Margins Return on Equity Return on Assets
Phio Pharmaceuticals Corp. 0.00% -411.5% -179.4%
Jaguar Health Inc. -933.26% -260% -87.4%

Volatility and Risk

A beta of 1.81 shows that Phio Pharmaceuticals Corp. is 81.00% more volatile than S&P 500. Competitively, Jaguar Health Inc.’s beta is 0.31 which is 69.00% less volatile than S&P 500.


The Current Ratio of Phio Pharmaceuticals Corp. is 1.8 while its Quick Ratio stands at 1.8. The Current Ratio of rival Jaguar Health Inc. is 0.5 and its Quick Ratio is has 0.3. Phio Pharmaceuticals Corp. is better equipped to clear short and long-term obligations than Jaguar Health Inc.

Insider and Institutional Ownership

Roughly 5.6% of Phio Pharmaceuticals Corp. shares are owned by institutional investors while 13.6% of Jaguar Health Inc. are owned by institutional investors. About 1.5% of Phio Pharmaceuticals Corp.’s share are owned by insiders. Comparatively, Jaguar Health Inc. has 17.39% of it’s share owned by insiders.


In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Phio Pharmaceuticals Corp. 9.09% -18.46% -75.17% -85.48% -93.68% -93.52%
Jaguar Health Inc. -27.15% -32.39% -50.32% -81.37% -82.69% -84.37%

For the past year Jaguar Health Inc. has weaker performance than Phio Pharmaceuticals Corp.


Phio Pharmaceuticals Corp. beats on 5 of the 9 factors Jaguar Health Inc.

Napo Pharmaceuticals, Inc., a human health company, focuses on developing and commercializing novel gastrointestinal prescription products from plants. Its products include Mytesi, an FDA approved product for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Napo Pharmaceuticals, Inc. was formerly known as PS Pharmaceuticals, Inc. The company was founded in 2001 and is based in San Francisco, California.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.